| Trial ID: | L0840 |
| Source ID: | IRCT2016080614882N4
|
| Associated Drug: |
Silymarin
|
| Title: |
Evaluation of sylimarin effect on non alcoholic fatty liver on children and adolescents
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
non alcoholic fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified Nonalcoholic fatty liver disease (NAFLD);Fatty (change of) liver, not elsewhere classified Nonalcoholic fatty liver disease (NAFLD)
|
| Interventions: |
Intervention 1: intervention group : Livergol tablet containing silymarin(Goldaru Company, Iran) were administered for 12 weeks with dosage of 5 mg per kg body weight divided in three dose with meal. Patients are visited weight, height and compliance
|
| Outcome Measures: |
Grading of fatty liver in sonography. Timepoint: At arrival to study and 12 weeks later. Method of measurement: Sonographic grading.Liver enzymes, transaminases. Timepoint: At arrival and after 12 weeks. Method of measurement: Serum.
|
| Sponsor/Collaborators: |
Vice Chancellor for Research of Shahrekord University of Medical Science
|
| Gender: |
All
|
| Age: |
5 years16 years
|
| Phases: |
Not applicable
|
| Enrollment: |
16
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Randomization was done base of random table number.
|
| Start Date: |
17/09/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/14348
|
